TY - JOUR
T1 - Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data
T2 - a cohort study
AU - The Consortium for Clinical Characterization of COVID-19 by EHR (4CE)
AU - Dagliati, Arianna
AU - Strasser, Zachary H.
AU - Hossein Abad, Zahra Shakeri
AU - Klann, Jeffrey G.
AU - Wagholikar, Kavishwar B.
AU - Mesa, Rebecca
AU - Visweswaran, Shyam
AU - Morris, Michele
AU - Luo, Yuan
AU - Henderson, Darren W.
AU - Samayamuthu, Malarkodi Jebathilagam
AU - Tan, Bryce W.Q.
AU - Verdy, Guillame
AU - Omenn, Gilbert S.
AU - Xia, Zongqi
AU - Bellazzi, Riccardo
AU - Aaron, James R.
AU - Agapito, Giuseppe
AU - Albayrak, Adem
AU - Albi, Giuseppe
AU - Alessiani, Mario
AU - Alloni, Anna
AU - Amendola, Danilo F.
AU - François Angoulvant, Angoulvant
AU - Anthony, Li L.L.J.
AU - Aronow, Bruce J.
AU - Ashraf, Fatima
AU - Atz, Andrew
AU - Avillach, Paul
AU - Azevedo, Paula S.
AU - Balshi, James
AU - Beaulieu-Jones, Brett K.
AU - Bell, Douglas S.
AU - Bellasi, Antonio
AU - Benoit, Vincent
AU - Beraghi, Michele
AU - Bernal-Sobrino, José Luis
AU - Bernaux, Mélodie
AU - Bey, Romain
AU - Bhatnagar, Surbhi
AU - Blanco-Martínez, Alvar
AU - Bonzel, Clara Lea
AU - Booth, John
AU - Bosari, Silvano
AU - Bourgeois, Florence T.
AU - Bradford, Robert L.
AU - Brat, Gabriel A.
AU - Bréant, Stéphane
AU - Brown, Nicholas W.
AU - Tseng, Yi Ju
N1 - © 2023 The Author(s).
PY - 2023/10
Y1 - 2023/10
N2 - Background: Characterizing Post-Acute Sequelae of COVID (SARS-CoV-2 Infection), or PASC has been challenging due to the multitude of sub-phenotypes, temporal attributes, and definitions. Scalable characterization of PASC sub-phenotypes can enhance screening capacities, disease management, and treatment planning. Methods: We conducted a retrospective multi-centre observational cohort study, leveraging longitudinal electronic health record (EHR) data of 30,422 patients from three healthcare systems in the Consortium for the Clinical Characterization of COVID-19 by EHR (4CE). From the total cohort, we applied a deductive approach on 12,424 individuals with follow-up data and developed a distributed representation learning process for providing augmented definitions for PASC sub-phenotypes. Findings: Our framework characterized seven PASC sub-phenotypes. We estimated that on average 15.7% of the hospitalized COVID-19 patients were likely to suffer from at least one PASC symptom and almost 5.98%, on average, had multiple symptoms. Joint pain and dyspnea had the highest prevalence, with an average prevalence of 5.45% and 4.53%, respectively. Interpretation: We provided a scalable framework to every participating healthcare system for estimating PASC sub-phenotypes prevalence and temporal attributes, thus developing a unified model that characterizes augmented sub-phenotypes across the different systems. Funding: Authors are supported by National Institute of Allergy and Infectious Diseases, National Institute on Aging, National Center for Advancing Translational Sciences, National Medical Research Council, National Institute of Neurological Disorders and Stroke, European Union, National Institutes of Health, National Center for Advancing Translational Sciences.
AB - Background: Characterizing Post-Acute Sequelae of COVID (SARS-CoV-2 Infection), or PASC has been challenging due to the multitude of sub-phenotypes, temporal attributes, and definitions. Scalable characterization of PASC sub-phenotypes can enhance screening capacities, disease management, and treatment planning. Methods: We conducted a retrospective multi-centre observational cohort study, leveraging longitudinal electronic health record (EHR) data of 30,422 patients from three healthcare systems in the Consortium for the Clinical Characterization of COVID-19 by EHR (4CE). From the total cohort, we applied a deductive approach on 12,424 individuals with follow-up data and developed a distributed representation learning process for providing augmented definitions for PASC sub-phenotypes. Findings: Our framework characterized seven PASC sub-phenotypes. We estimated that on average 15.7% of the hospitalized COVID-19 patients were likely to suffer from at least one PASC symptom and almost 5.98%, on average, had multiple symptoms. Joint pain and dyspnea had the highest prevalence, with an average prevalence of 5.45% and 4.53%, respectively. Interpretation: We provided a scalable framework to every participating healthcare system for estimating PASC sub-phenotypes prevalence and temporal attributes, thus developing a unified model that characterizes augmented sub-phenotypes across the different systems. Funding: Authors are supported by National Institute of Allergy and Infectious Diseases, National Institute on Aging, National Center for Advancing Translational Sciences, National Medical Research Council, National Institute of Neurological Disorders and Stroke, European Union, National Institutes of Health, National Center for Advancing Translational Sciences.
KW - COVID-19
KW - Electronic health records
KW - PASC
KW - Post-acute sequelae of SARS-CoV-2
KW - SARS-CoV-2
UR - http://www.scopus.com/inward/record.url?scp=85173054695&partnerID=8YFLogxK
U2 - 10.1016/j.eclinm.2023.102210
DO - 10.1016/j.eclinm.2023.102210
M3 - 文章
C2 - 37745021
AN - SCOPUS:85173054695
SN - 2589-5370
VL - 64
SP - 102210
JO - eClinicalMedicine
JF - eClinicalMedicine
M1 - 102210
ER -